Skip to Content


In the US, Zavesca (miglustat systemic) is a member of the drug class miscellaneous metabolic agents and is used to treat Gaucher Disease.

US matches:

UK matches:

Ingredient matches for Zavesca


Miglustat is reported as an ingredient of Zavesca in the following countries:

  • Australia
  • Austria
  • Belgium
  • Canada
  • Chile
  • Colombia
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Israel
  • Italy
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russian Federation
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Turkey
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.